Enhanced deoxyribonucleic acid damage and repair but unchanged apoptosis in uterine leiomyomas treated with gonadotropin-releasing hormone agonist

Buttram, 1981, Uterine leiomyomata: etiology, symptomatology and management, Fertil Steril, 36, 433, 10.1016/S0015-0282(16)45789-4 Liu, 1993, Medical treatment of uterine myoma with long-acting gonadotropin-releasing hormone agonist prior to myomectomy, J Formosan Med Assoc, 92, 650 Friedman, 1987, Treatment of leiomyomata with intranasal or subcutaneous leuprolide, a gonadotropin-releasing hormone agonist, Fertil Steril, 48, 560, 10.1016/S0015-0282(16)59464-3 West, 1987, Shrinkage of uterine fibroids during therapy with goserelin (Zoladex), a luteinizing hormone-releasing hormone agonist administered as a monthly subcutaneous depot, Fertil Steril, 48, 45, 10.1016/S0015-0282(16)59288-7 Lumsden, 1988, The binding of epidermal growth factor to human uterus and leiomyomata in women rendered hypoestrogenic by continuous administration of an LHRH agonist, Br J Obstet Gynaecol, 95, 1299, 10.1111/j.1471-0528.1988.tb06821.x Rein, 1990, The secretion of insulin-like growth factors I and II by explant culture of fibroids and myometrium from women treated with gonadotropin-releasing hormone agonist, Obstet Gynecol, 76, 388 Matta, 1988, Doppler assessment of uterine blood flow changes in patients with fibroids receiving gonadotropin-releasing hormone agonist buserelin, Fertil Steril, 46, 1083, 10.1016/S0015-0282(16)59966-X Costatini, 1990, Luteinizing hormone-releasing hormone analog therapy of uterine fibroid: analysis of results obtained with burserelin administered intranasally and goserelin administered subcutaneously as a monthly depot, Eur J Obstet Gynecol Reprod Biol, 37, 63, 10.1016/0028-2243(90)90096-J Colombel, 1992, Hormone-regulated apoptosis results from re-entry of differentiated prostate cells into a defective cell cycle, Cancer Res, 52, 4313 Berges, 1993, Cell proliferation, DNA repair, and p53 function are required for programmed death of prostatic glandular cells induced by androgen ablation, Proc Natl Acad Sci U S A, 90, 8910, 10.1073/pnas.90.19.8910 Huang, 1996, Intratumoral blood flow in uterine myoma correlated with a lower tumor size and volume, but not correlated with cell proliferation or angiogenesis, Obstet Gynecol, 87, 1019, 10.1016/0029-7844(96)00073-7 Harrison, 1993, Immunohistochemical evidence for the expression of proliferating cell nuclear antigen (PCNA) by nonproliferating hepatocytes adjacent to metastatic tumors and inflammatory conditions, J Pathol, 171, 115, 10.1002/path.1711710208 Garzetti, 1995, Ki67 antigen immunostaining (MIB 1 monoclonal antibody) in serous ovarian tumors: index of proliferative activity with prognostic significance, Gynecol Oncol, 56, 169, 10.1006/gyno.1995.1026 Weidner, 1991, Tumor angiogenesis and metastasis: correlation in invasive breast carcinoma, N Engl J Med, 324, 1, 10.1056/NEJM199101033240101 Li, 1995, Temporal profile of in situ DNA fragmentation after transient middle cerebral artery occlusion in the rat, J Cereb Blood Flow Metab, 15, 389, 10.1038/jcbfm.1995.49 Frisch, 1994, Disruption of epithelial cell-matrix interactions induces apoptosis, J Cell Biol, 124, 619, 10.1083/jcb.124.4.619 Tang, 1996, Role of apoptosis in growth and differentiation of proximal tubule cells in primary cultures, Biochem Biophys Res Commun, 218, 658, 10.1006/bbrc.1996.0118 Celis, 1986, Increased nuclear cyclin/PCNA antigen staining of non S-phase transformed human amnion cells engaged in nucleotide excision DNA repair, FEBS Lett, 209, 277, 10.1016/0014-5793(86)81127-9 Lee, 1990, Mechanism of elongation of primed DNA by DNA polymerase delta, proliferating cell nuclear antigen, and activator 1, Proc Natl Acad Sci U S A, 87, 5672, 10.1073/pnas.87.15.5672 Shivji, 1992, Proliferating cell nuclear antigen is required for DNA excision repair, Cell, 69, 367, 10.1016/0092-8674(92)90416-A Hall, 1994, Proliferating cell nuclear antigen expression in non-cycling cells may be induced by growth factors in vivo, Br J Cancer, 70, 244, 10.1038/bjc.1994.287 Li, 1994, Differential effects by the p21 CDK inhibitor on PCNA-dependent DNA replication and repair, Nature, 371, 534, 10.1038/371534a0 Smith, 1994, Interactions of the p-53 regulated protein Gadd45 with proliferating cell nuclear antigen, Science, 266, 1594, 10.1126/science.7973727 Sancar, 1994, Mechanisms of DNA excision repair, Science, 266, 229, 10.1126/science.7801120 Schwartz, 1995, Death by any other name, Am J Pathol, 147, 299 Oomens, 1991, Application of the monoclonal antibody Ki-67 on prostate biopsies to assess the proliferative cell fraction of human prostatic carcinoma, J Urol, 145, 81 Shaw, 1989, Mechanism of LHRH analogue action in uterine fibroids, Horm Res, 32, 150, 10.1159/000181332 Colgan, 1993, The histopathology of uterine leiomyomas following treatment with gonadotropin-releasing hormone analogues, Hum Pathol, 24, 1073, 10.1016/0046-8177(93)90186-K Gutmann, 1994, Evaluation of leuprolide acetate treatment on histopathology of uterine myomata, Fertil Steril, 61, 622, 10.1016/S0015-0282(16)56636-9 Hall, 1990, Assessment of cell proliferation in histological material, J Clin Pathol, 43, 184, 10.1136/jcp.43.3.184 Key, 1993, New Ki-67 equivalent murine monoclonal antibodies (MIB1-3) generated against bacterially expressed parts of Ki-67 cDNA containing three 62 base pair repetitive elements encoding for the Ki-67 epiotope, Lab Invest, 68, 629